Biofrontera (BFRIW) Payables (2020 - 2025)

Biofrontera's Payables history runs 6 years deep, the most recent figure standing at $4.9 million for Q4 2025.

• In Q4 2025, Payables rose 14.6% year-over-year to $4.9 million; the TTM figure through Dec 2025 stood at $4.9 million (up 14.6% YoY), while the FY2025 annual figure was $4.9 million, up 14.6% from the prior year.
• Payables was $4.9 million for Q4 2025 at Biofrontera, down from $6.6 million in the prior quarter.
• In the past five years, Payables ranged from a high of $11.0 million in Q3 2023 to a low of $269000.0 in Q1 2022.
• Historically, Payables has averaged $5.1 million across 5 years, with a median of $4.7 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Payables surged 1551.06% in 2022, then tumbled 57.83% in 2024.
• A 5-year view of Payables shows it stood at $658000.0 in 2021, then soared by 1551.06% to $10.9 million in 2022, then decreased by 22.76% to $8.4 million in 2023, then sank by 49.08% to $4.3 million in 2024, then climbed by 14.6% to $4.9 million in 2025.
• The last three Payables figures came in at $4.9 million (Q4 2025), $6.6 million (Q3 2025), and $5.8 million (Q2 2025), per Business Quant data.